Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Yingming Zhao
University of Chicago, Department: Internal Medicine/medicine
Should you be removed from our database? Contact us at [email protected]. Read more below.
Jingjie PTM Biolabs, LLC
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Dr. Yingming Zhao is founder and equity holder of Jingjie PTM Biolabs, LLC and does consulting work for the company. Jingjie PTM Biolabs, LLC reagents are provided at no charge to Dr. Zhao for use/application in the research study, but are not studied, tested or developed further.
Biochemistry of the lysine beta-hydroxybutyrylation pathway
Lysine beta-hydroxybutyrylation (Kbhb) is a new type of histone mark that is evolutionarily conserved, very dynamic and associated with multiple diseases. However, its biological function and key regulatory components remain unclear. The goals of this project are to characterize Kbhb pathway by identifying major histone Kbhb substrates, identifying its regulatory enzymes and binding proteins. This study thus will lay a solid foundation for studying functions of this pathway in cellular physiology and disease.
Filed on July 08, 2019.
Tell us what you know about Yingming Zhao's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Yingming Zhao filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Yingming Zhao | University of Chicago | Conflict of Interest | Jingjie PTM Biolabs, LLC | $60,000 - $79,999 |
| Yingming Zhao | University of Chicago | Conflict of Interest | Jingjie PTM Biolabs, LLC | $60,000 - $79,999 |
| Yingming Zhao | University of Chicago | Conflict of Interest | Jingjie PTM Biolabs, LLC | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.